Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federal register

Showing results (61-70 of 5,445) with videos related to

Pageof 545
Sort By:
Federal Register|November 28, 2001
Grants to states for construction and acquisition of state home facilities. Interim final rule
Federal Register|February 21, 2003
Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment
Federal Register|January 4, 2003
Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2003 and inclusion of registered nurses in the personnel provision of the critical access hospital emergency services requirement for frontier areas and remote locations. Final rule with comment period
Federal Register|February 13, 2003
Labeling requirements for systemic antibacterial drug products intended for human use. Final rule
Federal Register|January 28, 2003
Medicare and Medicaid programs; hospital conditions of participation: quality assessment and performance improvement. Final rule
Federal Register|December 17, 2002
Medical devices; reclassification of the cutaneous carbon dioxide and the cutaneous oxygen monitor. Final rule
Federal Register|October 3, 2002
International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice
Federal Register|October 3, 2002
International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice
Federal Register|October 3, 2002
Medicare program; supplementary medical insurance premium surcharge agreements. Final rule
Federal Register|September 25, 2002
International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS
Pageof 545

Showing results (61-70 of 5,445) with videos related to

Sort By:
Pageof 545
Federal Register|November 28, 2001
Grants to states for construction and acquisition of state home facilities. Interim final rule
Federal Register|February 21, 2003
Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment
Federal Register|January 4, 2003
Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2003 and inclusion of registered nurses in the personnel provision of the critical access hospital emergency services requirement for frontier areas and remote locations. Final rule with comment period
Federal Register|February 13, 2003
Labeling requirements for systemic antibacterial drug products intended for human use. Final rule
Federal Register|January 28, 2003
Medicare and Medicaid programs; hospital conditions of participation: quality assessment and performance improvement. Final rule
Federal Register|December 17, 2002
Medical devices; reclassification of the cutaneous carbon dioxide and the cutaneous oxygen monitor. Final rule
Federal Register|October 3, 2002
International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice
Federal Register|October 3, 2002
International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice
Federal Register|October 3, 2002
Medicare program; supplementary medical insurance premium surcharge agreements. Final rule
Federal Register|September 25, 2002
International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS
Pageof 545